Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.

@article{Curtis2010ElevatedLE,
  title={Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.},
  author={Jeffrey R. Curtis and Tim Beukelman and Alina Onofrei and Sarah E Cassell and Jeffrey David Greenberg and Arthur J Kavanaugh and George Reed and Vibeke Strand and Joel M. Kremer},
  journal={Annals of the rheumatic diseases},
  year={2010},
  volume={69 1},
  pages={43-7}
}
INTRODUCTION Potential hepatotoxicity associated with disease-modifying antirheumatic drugs (DMARDs) requires laboratory monitoring. In patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA), the incidence of elevated alanine aminotransferase/aspartate aminotransferase (ALT/AST) enzymes associated with methotrexate (MTX), leflunomide (LEF) and… CONTINUE READING